PILAR
MUÑIZ RODRIGUEZ
Catedrático de Universidad
Hospital de Cruces
Barakaldo, EspañaPublikationen in Zusammenarbeit mit Forschern von Hospital de Cruces (1)
2017
-
Indoleamine 2,3 dioxygenase as a prognostic and follow-up marker in melanoma. A comparative study with LDH and S100B
Journal of the European Academy of Dermatology and Venereology, Vol. 31, Núm. 4, pp. 636-642